BCR and B-cell chronic lymphocytic leukemia: Consistent with these data, it has been reported that loss of PTPROt in normal mice shows no significantly abnormal B cell activity, while PTPROt-deficient CLL mice exhibit higher tumor burden and shortened lifespan due to inhibition of the BCR signaling (54).